Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Dermatology

Why is a DH Biopsy Next to the Blister?

At a Glance

A dermatitis herpetiformis biopsy is taken from normal skin next to the blister, called perilesional skin, to ensure an accurate diagnosis. The active inflammation inside the blister destroys the IgA antibodies that doctors must find under a microscope to confirm the disease.

When you are being tested for dermatitis herpetiformis (DH), your dermatologist will perform a skin biopsy, which involves removing a small piece of skin for testing [1]. Patients often find it confusing when the doctor chooses to biopsy the normal-looking skin right next to a blister—known as perilesional skin—rather than taking a sample from the center of the rash itself [2]. This specific technique is not a mistake; it is actually a crucial step to ensure your diagnostic test results are accurate [3].

Why the Blister Itself Isn’t Reliable for this Test

Dermatitis herpetiformis is the skin manifestation of celiac disease, caused by your immune system reacting to gluten [4]. This reaction leads to deposits of an antibody called IgA in your skin [4]. When these IgA deposits build up, they trigger an intense inflammatory response that creates the intensely itchy blisters characteristic of the condition [5].

If a doctor were to biopsy the actual blister for this specific test, the intense inflammation and the active blistering process would have already destroyed the IgA antibodies at the center of the lesion [6]. The enzymes and immune cells that form the blister essentially chew up the very evidence the lab is trying to find [7]. Testing the blister directly often leads to a false-negative result, meaning the test comes back normal even though you actually have the disease [8].

Seeking the “Fingerprints” in Perilesional Skin

Instead of looking at the wreckage of the blister, the dermatologist looks for the “fingerprints” left just outside of it [1]. The normal-looking skin adjacent to your blister—the perilesional skin—contains intact, undamaged IgA antibodies that haven’t yet been destroyed by inflammation [2].

The lab uses a specialized test called Direct Immunofluorescence (DIF) on this sample [3]. Under a microscope, they apply a special dye that glows when it attaches to IgA antibodies. In a positive test for DH, they will see clear, granular deposits of IgA along the junction where the top and bottom layers of your skin meet [1]. Finding these granular deposits in the perilesional skin is the definitive way to confirm a dermatitis herpetiformis diagnosis [4].

What to Expect During the Procedure

Because looking for these IgA deposits is so specialized, your dermatologist might actually perform two separate punch biopsies (after administering a local numbing shot) [2]:

  • The DIF Biopsy: Taken from the normal-looking perilesional skin. This sample is placed in a special liquid (transport medium) that preserves the delicate IgA antibodies for the fluorescence test [3].
  • The Routine Biopsy: Often taken directly from the center of a blister [2]. This is placed in a standard preservative to be examined under a regular microscope, allowing the pathologist to look at the physical inflammation (such as clusters of immune cells).

By sampling both the “wreckage” of the blister and the “fingerprints” next to it, your care team gets the complete picture needed to confirm DH and guide your next steps, such as starting a strict gluten-free diet and consulting a gastroenterologist [4].

Common questions in this guide

Why doesn't the doctor biopsy the center of my dermatitis herpetiformis blister?
Biopsying the actual blister often leads to a false-negative result. The intense inflammation and enzymes that create the blister destroy the delicate IgA antibodies the lab needs to confirm a dermatitis herpetiformis diagnosis.
What is a perilesional skin biopsy?
A perilesional skin biopsy is a sample taken from the normal-looking skin immediately next to a lesion or blister. For dermatitis herpetiformis, this undamaged area contains the intact IgA deposits needed for an accurate test.
What does the lab look for in a dermatitis herpetiformis biopsy?
The lab uses a specialized Direct Immunofluorescence (DIF) test to look for granular deposits of IgA antibodies. Finding these specific deposits where the top and bottom layers of your skin meet is the definitive way to diagnose dermatitis herpetiformis.
Should I stop eating gluten before my dermatitis herpetiformis biopsy?
You should generally continue eating a normal diet with gluten until your biopsy is complete. Starting a gluten-free diet before the test can clear the IgA deposits from your skin, which may result in a false-negative biopsy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was a perilesional biopsy taken specifically for Direct Immunofluorescence (DIF), and was a separate sample taken from the blister itself for routine analysis?
  2. 2.Should I continue eating my normal diet containing gluten until the biopsy results are confirmed, since a gluten-free diet might affect the IgA deposits?
  3. 3.How long does it typically take for the DIF test results to come back from the lab?
  4. 4.If the perilesional biopsy is positive for IgA deposits, will you refer me to a gastroenterologist to discuss celiac disease testing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV).

    Görög A, Antiga E, Caproni M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(6)):1251-1277 doi:10.1111/jdv.17183.

    PMID: 34004067
  2. 2

    Celiac-Related Autoantibodies and IL-17A in Bulgarian Patients with Dermatitis Herpetiformis: A Cross-Sectional Study.

    Velikova T, Shahid M, Ivanova-Todorova E, et al.

    Medicina (Kaunas, Lithuania) 2019; (55(5)) doi:10.3390/medicina55050136.

    PMID: 31096650
  3. 3

    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet.

    Hietikko M, Hervonen K, Salmi T, et al.

    The British journal of dermatology 2018; (178(3)):e198-e201 doi:10.1111/bjd.15995.

    PMID: 28906552
  4. 4

    Reply letter to "An update on direct immunofluorescence for diagnosing dermatitis herpetiformis". Could granular C3 deposits at the dermal epidermal junction be considered a marker of "cutaneous gluten sensitivity"?

    Alice V, Corrà A, Caproni M

    Postepy dermatologii i alergologii 2021; (38(2)):346-348 doi:10.5114/ada.2021.106218.

    PMID: 34408602
  5. 5

    Etiopathogenesis of dermatitis herpetiformis.

    Rybak-d'Obyrn J, Placek W

    Postepy dermatologii i alergologii 2022; (39(1)):1-6 doi:10.5114/ada.2020.101637.

    PMID: 35369614
  6. 6

    A comparative study of expression of Fc receptors in relation to the autoantibody-mediated immune response and neutrophil elastase expression in autoimmune blistering dermatoses.

    Gornowicz-Porowska J, Seraszek-Jaros A, Bowszyc-Dmochowska M, et al.

    Polish journal of pathology : official journal of the Polish Society of Pathologists 2017; (68(2)):109-116 doi:10.5114/pjp.2017.69686.

    PMID: 29025244
  7. 7

    [Linear IgA bullous dermatosis].

    Juratli HA, Sárdy M

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(4)):254-259 doi:10.1007/s00105-019-4377-9.

    PMID: 30874843
  8. 8

    Dermatitis herpetiformis with fibrillar IgA deposition and unusual histologic findings.

    Miraflor AP, Paul J, Yan S, LeBlanc RE

    JAAD case reports 2017; (3(4)):344-347 doi:10.1016/j.jdcr.2017.04.003.

    PMID: 28761917

This page provides educational information on dermatitis herpetiformis diagnostic procedures. Always consult your dermatologist or healthcare provider for medical advice and to interpret your specific test results.

Get notified when new evidence is published on Dermatitis herpetiformis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.